These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31752868)

  • 1. Determinants of uptake of intermittent preventive treatment during pregnancy: a review.
    Roman E; Andrejko K; Wolf K; Henry M; Youll S; Florey L; Ferenchick E; Gutman JR
    Malar J; 2019 Nov; 18(1):372. PubMed ID: 31752868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of country adoption and implementation of the 2012 WHO recommendations for intermittent preventive treatment for pregnant women in sub-Saharan Africa.
    Henry M; Florey L; Youll S; Gutman JR
    Malar J; 2018 Oct; 17(1):364. PubMed ID: 30326904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing intermittent preventive treatment of malaria in pregnancy challenges: an ethnographic study of two Ghanaian administrative regions.
    Aberese-Ako M; Magnussen P; Gyapong M; Ampofo GD; Tagbor H
    Malar J; 2020 Sep; 19(1):347. PubMed ID: 32977827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
    Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
    PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
    Mbonye AK; Yanow S; Birungi J; Magnussen P
    BMC Pregnancy Childbirth; 2013 Sep; 13():178. PubMed ID: 24053142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the consistency of national-level policies and guidelines for malaria in pregnancy in five African countries.
    Gomez PP; Gutman J; Roman E; Dickerson A; Andre ZH; Youll S; Eckert E; Hamel MJ
    Malar J; 2014 Jun; 13():212. PubMed ID: 24888703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study.
    Ameh S; Owoaje E; Oyo-Ita A; Kabiru CW; Akpet OEO; Etokidem A; Enembe O; Ekpenyong N
    BMC Pregnancy Childbirth; 2016 May; 16():99. PubMed ID: 27147109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania.
    Marchant T; Nathan R; Jones C; Mponda H; Bruce J; Sedekia Y; Schellenberg J; Mshinda H; Hanson K
    Malar J; 2008 Dec; 7():260. PubMed ID: 19094198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria-related ideational factors and other correlates associated with intermittent preventive treatment among pregnant women in Madagascar.
    Awantang GN; Babalola SO; Koenker H; Fox KA; Toso M; Lewicky N
    Malar J; 2018 Apr; 17(1):176. PubMed ID: 29695231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The readiness of malaria services and uptake of intermittent preventive treatment in pregnancy in six sub-Saharan countries.
    Xu X; Liang D; Zhao J; Mpembeni R; Olenja J; Yam EL; Huang J
    J Glob Health; 2024 Jun; 14():04112. PubMed ID: 38939971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon.
    Diengou NH; Cumber SN; Nkfusai CN; Mbinyui MS; Viyoff VZ; Bede F; Akwah L; Tsoka-Gwegweni JM; Judith AK
    Pan Afr Med J; 2020; 35():42. PubMed ID: 32499857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to and use of preventive intermittent treatment for Malaria during pregnancy: A qualitative study in the Chókwè district, Southern Mozambique.
    Arnaldo P; Cambe MI; Magaço A; Chicumbe S; Rovira-Vallbona E; Rosanas-Urgell A; Enosse SM
    PLoS One; 2019; 14(1):e0203740. PubMed ID: 30677039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana.
    Vandy AO; Peprah NY; Jerela JY; Titiati P; Manu A; Akamah J; Maya ET; Torpey K
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):424. PubMed ID: 31747927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
    Arnaldo P; Rovira-Vallbona E; Langa JS; Salvador C; Guetens P; Chiheb D; Xavier B; Kestens L; Enosse SM; Rosanas-Urgell A
    Malar J; 2018 Mar; 17(1):109. PubMed ID: 29530044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015.
    Oppong FB; Gyaase S; Zandoh C; Nettey OEA; Amenga-Etego S; Anane EA; Adda R; Dosoo DK; Owusu-Agyei S; Asante KP
    BMJ Open; 2019 Jun; 9(6):e027946. PubMed ID: 31230017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.